FundCanna Secures $60M Credit Facility as Institutional Capital Expands Cannabis Finance Infrastructure

The cannabis industry has spent years operating inside a financial contradiction that would make a casino accountant sweat through his suit jacket. Legal across large sections of the United States. Generating billions in annual revenue. Employing thousands. Still treated by portions of traditional banking like somebody showed up requesting a wire transfer with a duffel bag and a fake passport. That disconnect created the opening for companies like FundCanna, a San Diego-based fintech and specialty lender focused entirely on cannabis finance infrastructure.

FundCanna, founded in 2021 by CEO Adam Stettner, secured a senior credit facility of up to $60M from a global institutional investment firm managing approximately $40B in assets under management (AUM). The transaction closed with an initial $35M funded immediately and increased FundCanna’s total capital position to roughly $75M. The company said the financing will support expansion of its cannabis lending platform and broader portfolio growth across regulated cannabis markets in the United States.

The deal matters because institutional capital rarely wanders into cannabis lending by accident. Federal banking uncertainty, fragmented state regulation, compliance exposure, and volatile operator economics have kept large portions of traditional finance sitting safely behind conference-room glass pretending caution is a growth strategy. FundCanna built directly inside that discomfort.

The financing also reflects a larger shift happening across specialty finance infrastructure and private credit markets. Investors are increasingly separating speculative cannabis operators from the financial infrastructure businesses supporting the ecosystem itself. That distinction changes how institutional money evaluates the entire sector.

What Happened

FundCanna operates as a specialty lender serving legal cannabis, hemp, CBD, and ancillary businesses across the United States. The company provides working capital, equipment financing, vendor financing, lines of credit, and embedded payment solutions for operators often excluded from traditional banking channels because of ongoing federal regulatory uncertainty and cannabis banking limitations tied to issues like the proposed SAFE Banking Act.

The new $60M senior credit facility gives FundCanna additional lending capacity at a moment when cannabis operators continue facing liquidity pressure, delayed vendor payments, tax burdens, and limited access to conventional credit markets. The institutional investor backing the facility was not publicly identified, though FundCanna disclosed the firm manages approximately $40B in AUM.

That detail matters more than people realize. This was not a speculative family-office side quest born during a golf trip and three margaritas near Palm Springs. Institutional underwriting teams evaluated cannabis credit exposure, repayment dynamics, compliance risk, and portfolio volatility, then approved the allocation anyway. In specialty lending, that qualifies as a loud statement delivered quietly.

FundCanna said the capital will support continued expansion of its lending platform as demand for cannabis-focused financing products grows nationwide. The company joins a broader wave of alternative lending market players building financial infrastructure around industries traditional banks still approach like they’re diffusing explosives in a hostage movie.

Why FundCanna Matters in Cannabis Finance

Cannabis businesses rarely fail because customers disappear overnight. They fail because timing breaks first. Inventory cycles collide with tax obligations. Vendor payments arrive late. Equipment costs stack up. Cash flow tightens while operators wait for capital access that traditional lenders still hesitate to provide.

Cannabis finance exists in an awkward collision between legal commerce and federal ambiguity. Banks fear compliance exposure. Credit committees fear reputational risk. Public institutions fear becoming tomorrow morning’s cable-news segment hosted by somebody who still thinks dispensaries operate out of Volkswagen vans parked behind music festivals. That fear created a fast-growing ecosystem of cannabis-focused fintech, private credit, and embedded finance platforms designed specifically for regulated operators.

FundCanna positioned itself directly inside that gap. Adam Stettner previously built Reliant Funding into a multi-billion-dollar small business finance company before launching FundCanna in 2021. The leadership team includes CRO Ryan Freitas, COO Eric Kaufman, General Counsel Mike Henshaw, EVP of Risk Management Joel Rose, VP of Sales Bill Gallagher, VP of Marketing JP Lagos, and VP of Technology Cagdas Ucar.

That operating background matters because cannabis lending is not branding theater disguised as finance. It is underwriting discipline mixed with regulatory navigation and risk management. One weak lending strategy inside cannabis can turn into a bonfire wearing a compliance badge.

The Bigger Shift Happening in Cannabis Infrastructure

A quieter transition is happening across cannabis markets right now. Early cannabis investment cycles revolved around cultivation expansion, retail footprints, consumer brands, and legalization momentum. A lot of capital chased narratives dressed like cultural revolutions. Some operators built durable businesses. Others treated investor money like bottle service during Art Basel week.

Now the market is maturing, and infrastructure is becoming more valuable than narrative. Payments, lending, compliance software, ERP systems, supply-chain platforms, and embedded finance tools are increasingly becoming the picks-and-shovels layer underneath cannabis commerce. Investors appear far more interested in operational durability than expensive celebrity-backed branding campaigns wrapped in neon packaging.

FundCanna’s ReadyPaid platform reflects that transition directly. ReadyPaid functions as a buy-now-pay-later financing solution designed for cannabis supply-chain transactions and vendor payments. The platform supports Net 30 and flexible payment terms while integrating directly into seller workflows as embedded financing infrastructure.

That may sound operationally boring compared to celebrity cannabis launches and giant retail expansion headlines. Markets eventually reward boring infrastructure because infrastructure survives downturns better than hype does. Chaos tends to market itself aggressively right before it collapses.

Institutional Capital Is Starting to Separate Signal From Noise

The cannabis industry has generated enough volatility over the past decade to make institutional investors cautious. Public cannabis stocks collapsed. State rollouts stalled. Regulatory fragmentation intensified. Tax burdens squeezed operators. Entire segments of the sector became graveyards filled with aggressive projections and investor decks pretending optimism qualified as unit economics.

Institutional capital did not disappear from cannabis entirely. It repositioned. Investors increasingly appear focused on infrastructure businesses supporting operational continuity inside regulated markets rather than speculative cultivation economics alone. Lending infrastructure, compliance systems, fintech rails, and enterprise financial services create recurring demand regardless of which operators ultimately dominate retail market share.

FundCanna fits directly into that infrastructure thesis. The company is not dependent entirely on consumer brand loyalty or retail foot traffic. Its position sits closer to the financial plumbing layer supporting cannabis commerce itself. Infrastructure businesses frequently survive market cycles better because operators still require financing, suppliers still require payment systems, and supply chains still require liquidity during difficult periods.

That shift also aligns with broader movement across venture debt and private credit markets, where investors increasingly favor cash-flow-oriented infrastructure businesses tied to operational dependence rather than speculative growth narratives alone.

What This Signals for Fintech and Specialty Lending

FundCanna’s financing says something broader about fintech markets in 2026. Specialty lending is becoming attractive again after years dominated by software valuations floating around like helium balloons cut loose during a children’s birthday party.

Investors increasingly appear focused on businesses tied to repayment behavior, infrastructure utility, credit performance, and operational necessity. That does not eliminate risk. Cannabis lending remains difficult. Regulatory uncertainty remains real. Political volatility remains real. Default exposure remains real. Sophisticated investors are simply beginning to evaluate those risks differently.

Markets mature when institutional capital develops enough confidence to separate operational infrastructure from speculative noise. FundCanna’s latest financing suggests cannabis finance may be moving toward that phase faster than many people inside traditional banking expected.

For broader fintech infrastructure coverage, the message is becoming difficult to ignore: institutional capital still moves toward necessity, even when regulation makes the room uncomfortable.